About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01645852

A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection

The purpose of this study is to measure the effect of a short-term low calorie diet on patients with a Body Mass Index (BMI) over 25 who are undergoing liver surgery.

Lead sponsor: Dartmouth-Hitchcock Medical Center•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Dartmouth-Hitchcock Medical Center

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age 18 or greater
•Clinical indication for a therapeutic liver resection
•BMI of 25 kg/m2 or greater
•Informed Consent

Exclusion Criteria

•Inability to comply with the pre-op diet
•Patients who have lost 5% or more of their usual body weight over the preceding one month
•Female patients of childbearing age who have a positive pregnancy test

Related studies

Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis

NCT03587831 · NASH - Nonalcoholic Steatohepatitis

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

NCT05623150 · Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and more

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

NCT07518784 · MASLD, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), and more

RECRUITINGPhase 3

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT06632444 · Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

NCT02815891 · Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 8, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment65

Start dateJun 2012

Last updatedFeb 8, 2017

Condition

Nonalcoholic Fatty Liver Disease Hepatic Steatosis Steatohepatitis

Locations shown

UMass Memorial Medical Center

Worcester, Massachusetts

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire

Fletcher Allen Health Care

Burlington, Vermont

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 8, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions